1459 related articles for article (PubMed ID: 33991487)
1. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
Deng X; Garcia-Knight MA; Khalid MM; Servellita V; Wang C; Morris MK; Sotomayor-González A; Glasner DR; Reyes KR; Gliwa AS; Reddy NP; Sanchez San Martin C; Federman S; Cheng J; Balcerek J; Taylor J; Streithorst JA; Miller S; Sreekumar B; Chen PY; Schulze-Gahmen U; Taha TY; Hayashi JM; Simoneau CR; Kumar GR; McMahon S; Lidsky PV; Xiao Y; Hemarajata P; Green NM; Espinosa A; Kath C; Haw M; Bell J; Hacker JK; Hanson C; Wadford DA; Anaya C; Ferguson D; Frankino PA; Shivram H; Lareau LF; Wyman SK; Ott M; Andino R; Chiu CY
Cell; 2021 Jun; 184(13):3426-3437.e8. PubMed ID: 33991487
[TBL] [Abstract][Full Text] [Related]
2. Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation.
Deng X; Garcia-Knight MA; Khalid MM; Servellita V; Wang C; Morris MK; Sotomayor-González A; Glasner DR; Reyes KR; Gliwa AS; Reddy NP; Martin CSS; Federman S; Cheng J; Balcerek J; Taylor J; Streithorst JA; Miller S; Kumar GR; Sreekumar B; Chen PY; Schulze-Gahmen U; Taha TY; Hayashi J; Simoneau CR; McMahon S; Lidsky PV; Xiao Y; Hemarajata P; Green NM; Espinosa A; Kath C; Haw M; Bell J; Hacker JK; Hanson C; Wadford DA; Anaya C; Ferguson D; Lareau LF; Frankino PA; Shivram H; Wyman SK; Ott M; Andino R; Chiu CY
medRxiv; 2021 Mar; ():. PubMed ID: 33758899
[TBL] [Abstract][Full Text] [Related]
3. The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.
Kim YJ; Jang US; Soh SM; Lee JY; Lee HR
Viruses; 2021 Apr; 13(4):. PubMed ID: 33917138
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
McCallum M; Bassi J; De Marco A; Chen A; Walls AC; Di Iulio J; Tortorici MA; Navarro MJ; Silacci-Fregni C; Saliba C; Sprouse KR; Agostini M; Pinto D; Culap K; Bianchi S; Jaconi S; Cameroni E; Bowen JE; Tilles SW; Pizzuto MS; Guastalla SB; Bona G; Pellanda AF; Garzoni C; Van Voorhis WC; Rosen LE; Snell G; Telenti A; Virgin HW; Piccoli L; Corti D; Veesler D
Science; 2021 Aug; 373(6555):648-654. PubMed ID: 34210893
[TBL] [Abstract][Full Text] [Related]
5. Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies.
Wahid M; Jawed A; Mandal RK; Dailah HG; Janahi EM; Dhama K; Somvanshi P; Haque S
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5857-5864. PubMed ID: 34604978
[TBL] [Abstract][Full Text] [Related]
6. Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity.
Kumar V; Singh J; Hasnain SE; Sundar D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502041
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
[TBL] [Abstract][Full Text] [Related]
8. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD
Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923
[TBL] [Abstract][Full Text] [Related]
9. Antibody cocktail effective against variants of SARS-CoV-2.
Liang KH; Chiang PY; Ko SH; Chou YC; Lu RM; Lin HT; Chen WY; Lin YL; Tao MH; Jan JT; Wu HC
J Biomed Sci; 2021 Nov; 28(1):80. PubMed ID: 34814920
[TBL] [Abstract][Full Text] [Related]
10. Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes.
Cheng L; Song S; Zhou B; Ge X; Yu J; Zhang M; Ju B; Zhang Z
Virol J; 2021 Apr; 18(1):87. PubMed ID: 33910569
[TBL] [Abstract][Full Text] [Related]
11. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Elife; 2020 Oct; 9():. PubMed ID: 33112236
[TBL] [Abstract][Full Text] [Related]
12. Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.
Kaku Y; Kuwata T; Zahid HM; Hashiguchi T; Noda T; Kuramoto N; Biswas S; Matsumoto K; Shimizu M; Kawanami Y; Shimura K; Onishi C; Muramoto Y; Suzuki T; Sasaki J; Nagasaki Y; Minami R; Motozono C; Toyoda M; Takahashi H; Kishi H; Fujii K; Tatsuke T; Ikeda T; Maeda Y; Ueno T; Koyanagi Y; Iwagoe H; Matsushita S
Cell Rep; 2021 Jul; 36(2):109385. PubMed ID: 34237284
[TBL] [Abstract][Full Text] [Related]
13. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
14. The effect of spike mutations on SARS-CoV-2 neutralization.
Rees-Spear C; Muir L; Griffith SA; Heaney J; Aldon Y; Snitselaar JL; Thomas P; Graham C; Seow J; Lee N; Rosa A; Roustan C; Houlihan CF; Sanders RW; Gupta RK; Cherepanov P; Stauss HJ; Nastouli E; ; Doores KJ; van Gils MJ; McCoy LE
Cell Rep; 2021 Mar; 34(12):108890. PubMed ID: 33713594
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
Collier DA; De Marco A; Ferreira IATM; Meng B; Datir RP; Walls AC; Kemp SA; Bassi J; Pinto D; Silacci-Fregni C; Bianchi S; Tortorici MA; Bowen J; Culap K; Jaconi S; Cameroni E; Snell G; Pizzuto MS; Pellanda AF; Garzoni C; Riva A; ; Elmer A; Kingston N; Graves B; McCoy LE; Smith KGC; Bradley JR; Temperton N; Ceron-Gutierrez L; Barcenas-Morales G; ; Harvey W; Virgin HW; Lanzavecchia A; Piccoli L; Doffinger R; Wills M; Veesler D; Corti D; Gupta RK
Nature; 2021 May; 593(7857):136-141. PubMed ID: 33706364
[TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential.
Lam B; Kung YJ; Lin J; Tseng SH; Tsai YC; He L; Castiglione G; Egbert E; Duh EJ; Bloch EM; Tobian AAR; Milstone AM; Roden RBS; Wu TC; Hung CF
Cell Rep; 2021 Oct; 37(3):109838. PubMed ID: 34648735
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
[TBL] [Abstract][Full Text] [Related]
18. Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination.
Wang M; Zhang L; Li Q; Wang B; Liang Z; Sun Y; Nie J; Wu J; Su X; Qu X; Li Y; Wang Y; Huang W
Emerg Microbes Infect; 2022 Dec; 11(1):18-29. PubMed ID: 34818119
[TBL] [Abstract][Full Text] [Related]
19. Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization.
Zhang L; Cui Z; Li Q; Wang B; Yu Y; Wu J; Nie J; Ding R; Wang H; Zhang Y; Liu S; Chen Z; He Y; Su X; Xu W; Huang W; Wang Y
Commun Biol; 2021 Oct; 4(1):1196. PubMed ID: 34645933
[TBL] [Abstract][Full Text] [Related]
20. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]